Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Turtle Cameron. Insider active across 1 company, notably Spyre Therapeutics, Inc.. Cumulatively, 20 reports have been published. Split: 0 buy · 18 sells. Total volume traded: €4.2m. History available since 24 November 2023. The latest transaction was filed on 3 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Turtle Cameron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
1,392 shares@ US$96.820.0016% mcap2.8% of flowCommon StockSEC:0001636282-26-000099:3
800 shares@ US$93.970.0009% mcap1.6% of flowCommon StockSEC:0001636282-26-000099:0
7,157 shares@ US$95.100.0083% mcap14.1% of flowCommon StockSEC:0001636282-26-000099:1
5,635 shares@ US$95.930.0066% mcap11.2% of flowCommon StockSEC:0001636282-26-000099:2
16 shares@ US$97.460.0000% mcap0.0% of flowCommon StockSEC:0001636282-26-000099:4
5,300 shares@ US$69.540.0047% mcap34.3% of flowCommon StockSEC:0001758363-26-000009:0
3,600 shares@ US$70.770.0032% mcap23.7% of flowCommon StockSEC:0001758363-26-000009:1
1,000 shares@ US$71.760.0009% mcap6.7% of flowCommon StockSEC:0001758363-26-000009:2
3,100 shares@ US$73.140.0029% mcap21.1% of flowCommon StockSEC:0001758363-26-000009:3
1,700 shares@ US$74.230.0016% mcap11.7% of flowCommon StockSEC:0001758363-26-000009:4
300 shares@ US$74.960.0003% mcap2.1% of flowCommon StockSEC:0001758363-26-000009:5
12,344 shares@ US$49.2033.7% of flowCommon StockSEC:0001758363-26-000007:0
2,656 shares@ US$49.927.4% of flowCommon StockSEC:0001758363-26-000007:1
5,900 shares@ US$41.737.1% of flowCommon StockSEC:0001636282-26-000026:0
957 shares@ US$31.820.9% of flowCommon StockSEC:0001758363-26-000005:0
12,709 shares@ US$30.4711.1% of flowCommon StockSEC:0001758363-26-000002:0
10,995 shares@ US$28.7311.4% of flowCommon StockSEC:0001758363-25-000003:0
28,155 shares@ US$23.1326.7% of flowCommon StockSEC:0001636282-25-000106:0
400 shares@ US$9.82100.0% of flowCommon StockSEC:0000950170-24-017494:0
723,440 shares0Common StockSEC:0000950170-23-066131:0
About Turtle Cameron
Turtle Cameron appears in 15 filings. In the sampled recent filings, all transactions are sales in Spyre Therapeutics, Inc., where the listed role is Chief Executive Officer, with total sell volume of EUR 2952878 between 2023-11-27 and 2026-05-01.